Overview
Whether you arrived from a “KAS vs Injective” query or from PEPS coin pages, this hub aggregates ranks, performance and module-backed signals into one canonical URL.
Quick winners
Full comparison
| Metric | KAS | INJ |
|---|---|---|
| Price | $1,861.70 | $4.99 |
| Market Cap | $737.98M | $490.41M |
| FDV | — | — |
| Volume 24h | $5.68M | $2.65M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 80.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | KAS | INJ |
|---|---|---|
| 1H | — | — |
| 24H | -1.00% | +1.03% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | KAS | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.07 |
| Trend | bearish | neutral |
| Momentum | 65.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Use the indicator table as a checklist: if momentum and trend align on one asset while the other diverges, relative-value setups become more interesting — still without certainty.
Fundamentals
| Metric | KAS | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
KAS
Injective
Pros and cons
Pros of KAS
- Composite PEPS readings for KAS can surface clearer module agreement during trend phases.
- Market-cap scale on KAS may dampen some idiosyncratic shocks versus smaller peers.
- Higher ranking for KAS can translate into tighter spreads on major venues.
Cons of KAS
- When dominance narratives fade, KAS can lag hotter rotation names.
- Large-cap status for KAS can mean slower percentage upside versus high-beta alternatives.
- Indicator stacks on KAS may stay stretched longer than expected in strong trends.
Pros of Injective
- Diversifying versus KAS with Injective can change portfolio factor exposure.
- If technical momentum aligns, Injective may outperform on medium-term windows.
- Narrative optionality around Injective can reprice quickly when catalysts appear.
Cons of Injective
- Smaller book depth versus large caps can increase slippage for Injective.
- Trend failures on Injective often travel faster than on more established assets.
- Incomplete fundamental coverage can hide operational or tokenomic risks.
- Weaker market-cap standing may leave Injective more exposed to liquidity droughts.
Which looks stronger right now?
Statistically, higher market cap (KAS) often correlates with deeper books, while hotter 24h prints (Injective) can fade. Position sizing should reflect that uncertainty.
AI summary
This AI-assisted summary starts from live PEPS fields. KAS holds market-cap $737.98M and rank #80; Injective shows $490.41M and #99. Where liquidity and flow matter, watch KAS. Where durability matters, watch KAS. AI composite scores (57.80/46.90) compress those tensions into a single lens. In probabilistic terms, the side winning more columns may have a nearer-term edge, but tails remain fat. Revisit after the next hourly refresh.
FAQ
Which is better, KAS or Injective?
“Better” depends on horizon and risk. KAS leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, KAS or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both KAS and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. KAS currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.